About Almac Group
‘Partnering to Advance Human Health’

Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services to the pharmaceutical and biotech sectors globally. Solutions range from R&D, biomarker discovery development and commercialisation, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture and pack.

The privately owned, global organisation has grown organically over 50 years now employing over 5,600 highly skilled personnel and has a strong reputation for innovation, quality and exceptional customer service. 

The Group is headquartered in Northern Ireland with 18 operations across Europe, the US (Pennsylvania, North Carolina and California) and Asia (Singapore and Tokyo).

Sales Markets

Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Central/South America; East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info

Top Products

Our Resources

Categories affiliated with Almac Group ltd